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Thegeneralcentraldogmaframestheemergentpropertiesoflife,whichmakebiologybothnecessaryanddiﬃculttoengineer.Ina
process engineering paradigm, each biological process stream and process unit is heavily inﬂuenced by regulatory interactions and
interactions with the surrounding environment. Synthetic biology is developing the tools and methods that will increase control
over these interactions, eventually resulting in an integrative synthetic biology that will allow ground-up cellular optimization. In
this review, we attempt to contextualize the areas of synthetic biology into three tiers: (1) the process units and associated streams
of the central dogma, (2) the intrinsic regulatory mechanisms, and (3) the extrinsic physical and chemical environment. Eﬀorts
at each of these three tiers attempt to control cellular systems and take advantage of emerging tools and approaches. Ultimately,
it will be possible to integrate these approaches and realize the vision of integrative synthetic biology when cells are completely
rewired for biotechnological goals. This review will highlight progress towards this goal as well as areas requiring further research.
1.Introduction
The central dogma of biology is simply and elegantly stated;
however it is less straightforward to engineer, control, and
rewire for biotechnological purposes. This diﬃculty stems
from our limited understanding of the multiscale, and
often stochastic, operation, and regulation of biological
systems [1–3]. Nevertheless, rapid progress in uncovering
the basic framework and information ﬂow within the
central dogma has helped fuel the current biotechnological
revolution. Yet, elucidating the speciﬁc components and
control mechanisms inherent in this process has lagged
signiﬁcantly [4–6]. This limitation prevents the creation
of custom-built cellular factories using modeling and de
novo design. However, this limitation is only temporary.
Recent advances in high-throughput biology are quickly
uncovering the identity and details of these components
and control schemes [7–10]. While not yet complete, this
global, systems biology approach repeatedly depicts the
central dogma as a multistep process subject to exquisite
regulatory mechanisms established to maintain cellular
homeostasis and to respond to environmental stimuli.
Once our understanding is advanced, it will be possible
to synthetically create desired functions at all levels of the
central dogma.
The integrative complexity of the central dogma (and
biological systems in general) has analogies and parallels to
chemical or electrical systems. The rationale for drawing
these analogies is twofold: (1) it helps to contextualize the
various parts of a cellular process and (2) it facilitates
the possible transfer of knowledge between the analogous
systems. In this regard, understanding the central dogma
processes, the process controls, and the environmental
inﬂuences within a cell is as vital as understanding anal-
ogous components within a traditional chemical factory.
Uncovering and studying these components will ultimately
lead to a factory-like cellular blueprint—a detailed catalogue
of parts, interactions, and functions. Moreover, compiling
such a blueprint for all species will expand the number of
parts we are able to access, characterize, and employ when
trying to design cells and circuits from scratch. Thus, this
understanding will enhance our ability to predict, control,
and design cellular systems—major tenets in the emerging
ﬁeld of synthetic biology.2 Journal of Biomedicine and Biotechnology
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Figure 1: The central dogma with regulatory and environmental
inﬂuences acting upon the process.T h et w oc e n t r a ld o g m ap r o c e s s
units (transcription and translation) and the three process streams
(DNA, RNA, and protein) are depicted. These units and streams
are all subject to control by both internal, regulatory and external,
environmental conditions. These inﬂuences alter the central dogma
process and regulatory mechanisms. Large bold arrows are used
to indicate that proteins are the major workhorses of the cell,
participating both in regulatory mechanisms and responding to the
environment. Whether the system of interest is a signaling cascade
or metabolic pathway, proteins are essential components and must
become well understood and modiﬁable to bring about ground-
up cellular optimization. Synthetic biology is developing tools to
modify and control each unit and stream in this process.
Due to its youth, the ﬁeld of synthetic biology has yet to
haveaconcrete,comprehensivedeﬁnition.Yet,initsbroadest
sense,syntheticbiology aimstoharnesstheemergentproperties
of the central dogma for biotechnological and human use.
This description of the ﬁeld is comprehensive since even
synthetically designed biological circuits actually interface
with existing central dogma machinery in the cell. In this
regard, tools for synthetic biology harness the complexity of
the central dogma process in a predictable, designed fashion.
Within the context of engineering the central dogma, the
seemingly wide variety of themes and aims in the synthetic
biology research ﬁeld become more uniﬁed. Considering the
central dogma as a simple process diagram (Figure 1), it can
be seen that the varied areas of synthetic biology research all
inﬂuencethecentraldogmaalbeitatdiﬀerentaccesspointsin
the process. As Figure 1 illustrates, this system has three tiers,
speciﬁcally:(1)thecentraldogmaprocessunits(transcription
and translation) and associated streams (DNA, RNA, and
protein), (2) the intrinsic regulatory mechanisms in the cells,
and (3) the extrinsic physical and chemical environment of
the cells. These three tiers are depicted separately, but in
reality are thoroughly enmeshed with one another as a result
of evolved biological complexity. Yet, this very complexity
provides a multitude of access points, or nodes, for synthetic
biologists to engineer.
Synthetic biology research is at the forefront of engineer-
ing the three tiers of biological systems. For example, the
newly developed ability to design and chemically synthesize
genetic sequences [11–13]p r o v i d e sag r e a t e ra b i l i t yt o
manipulate DNA, the “feed stream” molecule for the ﬁrst
tier. Contributions from systems biology have broadened
our ability to understand and engineer biological networks
[14–18], providing impetus for modifying tier two intrinsic
controlsystemsandtierthreeextrinsicsignalinginteractions.
Other frontiers in synthetic biology have greatly expanded
our capacity to construct and improve pathways and global
cellular phenotype [19–24], which engineers the third tier
interaction between proteins and the chemical environment.
In the same vein, protein engineering provides the synthetic
biologist a great deal of ﬂexibility for introducing and opti-
mizing new function at any node [25–31], since proteins are
such universal components throughout the central dogma
process. All of these areas of synthetic biology are building
toward a single goal: integrative control of the central dogma
for biotechnological and human use.
From this viewpoint, developing powerful new tools
that manipulate biology at each of the three tiers will
empower scientists and engineers with the ability to rewire
and program cellular systems for both medical and biotech-
nological applications. Combining these tools to work in
concert would deﬁne the ﬁeld of integrative synthetic biology.
This culminating point of synthetic biology development
will usher in the age of ground-up cellular design and
optimization. However, much of current synthetic biology
research is focused on tool development, a required foun-
dation for integrative synthetic biology. As a result, it is not
yet clear how to best integrate these approaches. Therefore,
the purpose of this review is to provide an overview of
synthetic biology research, focusing on microbial hosts,
and to highlight areas where more work must be done
before realizing the potential of ground-up synthetic cellular
engineering.
2. The FirstTier—Process Optimization of
theCentralDogma
The ﬁrst tier of synthetic biology focuses on altering
the general process ﬂow—speciﬁcally modiﬁcations to the
function and behavior of the process units (transcription
[32] and translation) and the associated process streams
(DNA, RNA [33], and protein). These manipulations are
made possible through detailed knowledge of the central
dogma process. While this capacity has existed for several
decades [34], novel capabilities and genetic tools aﬀorded by
synthetic biology may help overcome some of the limitations
and time-consuming bottlenecks inherent in established
techniques. In this regard, synthetic biology aims to develop
foundational technologies such as large-scale, economical de
novo DNA synthesis [35] that would increase the eﬃciency
of traditional recombinant DNA technology and genetic
engineering.Collectively,syntheticengineeringofthecentral
dogma aims to optimize and expand the capabilities of
native cellular machinery. The methods and technologiesJournal of Biomedicine and Biotechnology 3
developed from this research will contribute to a more
powerful and eﬃcient toolbox for the microbial engineer.
In this section, we will review synthetic biology technologies
and applications for inﬂuencing components within the ﬁrst
tier.
2.1. Engineering DNA. DNA manipulation began very early
in the biotechnological revolution with recombinant DNA
methods [36–38] and DNA sequencing technology [39–
41]. Mutagenesis techniques and the establishment of stan-
dardized molecular biology methods [34] expanded these
tools and empowered metabolic engineers with more pow-
erful approaches to improve metabolic phenotypes [42–46].
Despite being straightforward and robust, these approaches
are inherently limited by template-based DNA synthesis and
restrictionenzymecloning.However,inexpensive,largescale
synthetic (de novo) DNA manufacturing technology has the
potential to revolutionize this process once again. Unlike
traditional methods, de novo synthesis removes the need
to engineer cellular systems using preexisting DNA as a
template. In this regard, this technology brings about a new
power to synthetically design genes, control elements, and
circuits that do not exist in nature—thus creating novel
function from the basic building blocks of nucleic acids and
amino acids.
Already, there are multiple companies with expertise in
synthesizing DNA (Blue Heron, DNA2.0, GENEART, IDT,
etc.), from small fragments to whole genes and genetic
elements.Moreover,improvementsandnewtechnologiesare
continually being published [12, 35, 47–50] which expand
the potential applications and drive down prices. As a result,
synthesis capabilities have moved beyond the scale of single
genes and into the scale of chemically synthesized genomes
[11, 13]. Moreover, eﬀorts are being made to introduce
this synthetic DNA into a generic host [51]i na ne ﬀort
to completely reprogram a cell. The combination of these
powerful new DNA synthesis techniques coupled with low-
cost DNA sequencing has the potential to confer a great deal
of freedom to researchers. With these advances, DNA design
and cloning is no longer limited by existing fragments of
template DNA and available restriction sites in plasmids. In
essence,thistechnologyservesasthebasisforothersynthetic
biology tools, since DNA is the vehicle of almost every
biological perturbation, regardless of the tier of interest.
However, our ability to create DNA de novo is not equally
matched by a capacity to predict the ideal DNA sequence a
priori f o rag i v e na p p l i c a t i o n .A t t e m p t sh a v eb e e nm a d et o
catalogue DNA elements [52, 53] and predict the function
of synthetic networks using models [9, 15, 17, 18, 54].
Nevertheless, our knowledge base for constructing predictive
models of global cellular behavior is limited as is our ability
to design large operons and circuits de novo.F u t u r ew o r k
on characterizing these elements as well as their dynamics
and interaction will allow for synthetically created custom-
designed genetic circuits.
Simply synthesizing and importing designed DNA is
not enough to ensure desired function. Speciﬁcally, for
these elements to operate eﬃciently, synthetic DNA operons
must act independently and not be negatively inﬂuenced by
other cellular processes. One solution to mitigate this prob-
lem embodies another area of synthetic DNA engineering
research: the quest for a minimal cell [55–57]. A minimal cell
only contains the essential genetic information required to
maintain viability under controlled conditions. In following
with the industrial process analogy, this would correspond to
afactorycontainingonlytheequipmentnecessaryforagiven
process application. It is clear that this minimization makes
sense in a process plant as superﬂuous equipment would
be a waste of precious resources such as money and space.
However, cells contain many more parts than are necessary
for a given biotechnological application. Thus, taking a cell
“oﬀ the shelf” can result in limited eﬃciency. The search for
a minimal cell provides a noninterfering “chassis” suitable
for manipulation by the biological engineer. Recent advances
in cataloging essential genes continue to move the minimal
cell closer to reality [58, 59]. However, it is currently unclear
whether the genetic deﬁnition of a minimal cell will be
generic or process speciﬁc. Thus, there may be a suite of
minimal cells required; each one suited for diﬀerent classes
of bioproducts.
Another area of synthetic DNA engineering aims to
expand the basic genetic code by adding synthetic base pairs
[60–63]. Incorporating synthetic codons provides a means
of utilizing nonnatural amino acids (see Section 2.3)a n d
introducing nonnative DNA-protein binding pairs. Already,
a l t e r n a t i v eg e n e t i cc o d e sh a v el e dt on e wa p p l i c a t i o n sf o r
engineered biology [61]. One of the potential diﬃculties of
incorporatingsyntheticbasepairsintoDNAisthatthethree-
dimensional structure of the molecule may change and key
binding proteins and polymerases may not be able to rec-
ognize the new genetic language. However, initial results are
promising [63, 64] and suggest that drastic changes to innate
cellular architecture are not required. Thus, alternative base
pairsprovideanewfoundﬂexibilityingeneticcodeandDNA
manipulation technology. Furthermore, this approach is an
excellentapplicationfordenovoDNAsynthesis:thecoupling
of synthetic base pairs with DNA synthesis technology
could create a powerful tool for designing synthetic circuits.
Regardless of the application, the capacity to engineer DNA
using synthetic biology tools provides new access points to
the cell unachievable by previous technology.
2.2. Engineering Transcription. Since the central dogma is so
highly integrated, DNA-level perturbations can cause signif-
icant alterations in downstream process units (Figure 1). As
a result, microbial engineers must be able to synthetically
optimize each of the process units. The ﬁrst process unit
in the central dogma is transcription. A large number
of proteins, small molecules, and even small RNAs can
participate in this process step [5]. Nevertheless, the ultimate
goal of this process is RNA transcription—converting DNA
into an mRNA message. As a result, synthetic control of
this process step inﬂuences the rate and capacity of mRNA
synthesis.
Notsurprisingly,thekeystepofRNApolymeraseIIbind-
ing to a promoter sequence has been targeted by synthetic4 Journal of Biomedicine and Biotechnology
tools, such as promoter engineering, for the purposes of con-
trolling gene expression levels [65–68]. By creating a library
of promoter sequence mutants, a graduated expression
proﬁle can be developed. This resulting range of expression
aﬀords a more detailed investigation of expression levels
beyond traditional wild type—knockout—strong overex-
pression studies. Furthermore, well-characterized promoters
enable more precise gene delivery [52]. A similar require-
ment for controlled expression is critical for genetic circuits
where protein expression must be balanced to maintain
a desired steady state. Often these circuits use inducible
promoters, and a similar approach can be used to augment
the expression capacity of inducible promoters. Thus, well-
documented genetic elements will be extremely useful in
creating synthetic cells and circuits. However, transcription
is a two-body problem requiring both proteins and DNA.
Most previous work focused on the DNA aspect of the
problem; however, proteins involved in transcription can
also be engineered to synthetically control a cell [32].
Moreover, altering the DNA sequence focuses the change to
one particular genetic locus, whereas changing the involved
proteins has a profound, global impact.
It is often necessary to alter the transcriptional proﬁle
of many genes simultaneously to obtain a desired complex
phenotype. This level of synthetic control in the cell is
essential for rewiring cells into biofactories. In this regard,
another synthetic biology tool termed global transcription
machinery engineering (gTME) [30, 69, 70]a i m st oa l t e r
the proteins responsible for the process step of transcription
in an eﬀort to exert a pleiotropic downstream eﬀect. The
gTME approach operates by creating a mutant library of
proteins responsible for transcription (such as sigma factors
and TATA binding proteins) and subjecting the library to a
high-throughput phenotype screen. This technique is useful
for a phenotype that is typically under the control of a
multitude of genes. This approach of synthetically rewiring
cells at the transcriptional level provides a means of creating
large changes within the transcriptome and provides a novel
approach to modulating the process step of transcription.
The rationale behind gTME was recently applied to
the RNA polymerase II protein itself [32]. By creating a
mutant library of the polymerase α subunit and applying
selective pressures, the authors demonstrated increases in
the tolerance of E. coli to 1-butanol. More studies such as
these are required not only to optimize the transcription
process unit for synthetic biology applications, but also
to gain more fundamental knowledge of the process unit.
With enough information, rational design of synthetic
transcriptional machinery may be possible. However, large-
library based selection techniques are currently required to
identify promising mutants, limiting the capacity to design
transcription machinery de novo.
Also of note for future synthetic biology tool devel-
opment is reverse transcription, illustrated by the double-
pointed arrows in Figure 1. Reverse transcription as a
method of gene delivery for disease treatment [71, 72]m e ri t s
furtherexplorationbysyntheticbiologists,althoughthistype
of work is generally outside the focus of microbial synthetic
biologists. Yet, a great deal of work still remains prior to
gaining full, synthetic control of the transcription process.
Speciﬁcally, more studies focusing on the complex interac-
tions between participatory molecules must be performed.
These studies will also implicate future molecular targets for
strategies similar to promoter engineering and gTME.
2.3. Engineering Translation. The second major process unit
in the central dogma, translation, has also been the subject
of recent synthetic biology research. Similar to transcription,
translation encompasses many diﬀerent classes of molecules
that can serve as good targets for optimization and rewiring
cells. However, less is known about the most essential
molecules in this process.
One of the most successful examples of synthetically
engineering translation machinery involves the incorpo-
ration of unnatural amino acids into proteins [73]. In
this work, mutant aminoacyl tRNA synthetases incorporate
amino acids with diverse R-group chemistries into proteins.
This approach holds a great deal of promise for the synthetic
biologist as a means of creating wholly new biological func-
tions and chemistries [29, 74–76]. This direction towards
designer proteins is akin to nontemplate based DNA synthe-
sis. However, as with de novo DNA synthesis, it is not always
clearwhichaminoacid(s)shouldbechangedtoanunnatural
analog to confer a desired protein function of interest. In this
regard, more work is required to develop a computational
linkage between sequence and function. Nevertheless, this
approach gives signiﬁcant leverage to synthetic biologists to
create custom proteins with desired functions.
Another example of engineering translation is gene
codon optimization [33]. Codon optimization is a method
to bias the redundant codons for each amino acid toward
the codons most commonly found in the host organ-
ism. This approach is greatly expedited by sequencing
and synthesis technologies that can produce the required
alternately coded genes. Codon optimization has been
shown to be successful in many cases [77–82] and has
led to improved translation rates, protein yields, and enzy-
matic activities. When combined with pathway engineering,
codon-optimized pathways are typically more eﬃcient than
their unengineered counterpart. This approach is especially
important when attempting to produce natural products
found in systems distantly related to the host organisms
(such as importing plant genes into E. coli [83]). Finally,
computational techniques are continually being developed
to perform the task of codon optimization and assembly
design which will improve our ability to control this process
step [84]. However, recent evidence has shown that codon
optimization may be more eﬀective due to changes in mRNA
secondary structure, as opposed to making more abundant
tRNA available for translation [85]. Engineering mRNA
secondary structure is a second-tier, regulatory method of
controlling the central dogma, and is discussed in that
section. With these emerging questions, it remains to be seen
if the combination of de novo DNA synthesis with codon
optimization algorithms will greatly expedite this process
and remove some translation-level limitations in cellular
systems.Journal of Biomedicine and Biotechnology 5
2.4. Engineering the First Tier—Summary. The techniques
and approaches described above focus on a synthetic
approach aimed to redesign the information and process
ﬂow in the central dogma. As Figure 1 suggests, manipula-
tion of the central dogma process at any one of the nodes
often results in changes at the protein level. As the major
catalytic, structural, and signaling components of cells,
synthetically modifying proteins is one of the primary goals
of engineering biology. Some of these manipulations, such as
promoter engineering and codon optimization, are designed
to alter protein level, while others, such as directed evolution
[25, 86, 87] and unnatural amino acids, are intended to
syntheticallyalterproteinfunctiondirectly.Ineithercase,the
change must be made at the ﬁrst tier in order to create the
downstream eﬀect.
The tools of synthetic biology in this arena have
improved the rate and precision of changes that can be
made to this ﬁrst tier. Moreover, they open the capacity
to design novel elements and process units that serve a
higher biotechnological goal. Yet, more work is required to
enable full de novo design of these custom-made elements.
In addition, the complete rewiring of cells will likely require
multiple modiﬁcations in the ﬁrst tier, thus these approaches
must be used in combination to obtain the best results for
bioprocessing applications.
3. The Second Tier—Engineering
Process Controls
A myriad of control systems have evolved to regulate the
highly complex process steps of the central dogma. As a
result of tight integration between process and control,
it is sometimes diﬃcult to clearly delineate between the
biological components of control mechanisms and the
central dogma process ﬂow. For this review, we propose that
microbial control mechanisms are largely those components
that interface with the central dogma process steps, but
do not function in a catalytic manner with respect to
the process step. Using the process control analogy, these
components establish, alter, and regulate the biological “set
points.” Figure 2 depicts hypothetical control mechanisms
within the cell to more clearly delineate between the
various tiers of cellular processes. Generally, these control
elements form a functional link between the central dogma
process (the ﬁrst tier) and the extrinsic environment (the
third tier) and relay control messages into changes in
the process units and streams. Actual control mechanisms
within the cell are much more complex than this simple
depiction, as studies on the RpoS subunit of E. coli RNA
polymerase II have shown [88]. To this end, the systems
biology approach of surveying global protein-protein inter-
actions is pivotal to understanding these complex mecha-
nisms.
Even without full knowledge of cellular regulatory
machinery, synthetic biologists have developed tools that
establish desirable synthetic set points for the central dogma
process units. These tools are required for the function
of genetic circuits and control of metabolic pathways. In
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Figure 2: Interaction of components illustrating synthetic biology
at the three tiers. (a) Canonical signalling pathway depicting a
tier three ligand-receptor binding event that induces a tier two
phosphorylation cascade which subsequently alters a promoter
at the ﬁrst tier. (b) Canonical allosteric protein inhibition by a
molecule downstream in the pathway. The inhibition binding event
is a tier three interaction which results in a tier two alteration in the
pathway “set point.” (c) Hypothetical signalling pathway in which
a signal molecule alters an initiation factor at tier three which then
changes the tier two protein translation set point.
this section, we will review enabling technologies and
applications for synthetic engineering of process control
systems within the second tier.
3.1. TranscriptionalControl. As stated previously, the control
elementsinvolvedinmanysignalingandregulatorynetworks
are being uncovered using a systems biology approach.
In particular, these studies are uncovering the important
roles that transcription factors play in the process unit
of transcription [7, 9, 59, 89]. Typically, these interac-
tion networks are reconstructed using high throughput
data obtained from two-hybrid, coimmunoprecipitation, or
bioinformatic mining protocols. These studies have pro-
duced a wealth of data for analysis, although the data is
often collected outside of biologically relevant conditions
[90]. Recent work is attempting to improve upon these
techniques by collecting protein interaction data in native
systems with natural protein expression levels [90]. Even
with preliminary data and targets, attempts to engineer
transcription factor networks have shown promise [31]. If
this knowledge gap is closed, imported synthetic circuits
and genes could act independently and not be negatively
inﬂuenced by other cellular processes. Moreover, com-
ponents of transcription represent a target and provide
an access point for synthetic biologists to eﬀect change
in biological systems. Therefore, transcriptional control
networks should remain an active area of research for
synthetic biologists in order to close this knowledge gap
and open the possibility for ground-up cellular optimiza-
tion.6 Journal of Biomedicine and Biotechnology
3.2. Translational Control. In the past few years, a great
interest has arisen in the synthetic engineering of RNA
[91, 92]. From a process engineering perspective, RNA serves
both as the “feed stream” to the translation process unit and
as a central component of the translational machinery itself.
Therefore, depending on the application and desired output,
engineering of RNA to alter translation can be classiﬁed as
a ﬁrst-tier or a second-tier approach to synthetic biology.
In terms of translational control, it has been demonstrated
that modifying mRNA structure can modulate protein levels
[93, 94]. As an example, by optimizing intergenic regions
in an operon [95], hairpins that sequestered ribosomal start
codons were introduced and aﬀorded synthetic control of a
bicistronic message. Also, similar work has been performed
to identify and engineer synthetic ribosome entry (IRES)
sites for polycistronic transcripts [96]. Finally, Breaker and
colleagues have focused a great deal of eﬀort to the under-
standing of native RNA response to small molecules [97, 98].
These ﬁndings along with research on riboswitches could
begin to link translational control with signaling networks
or environmental signals (for more on this topic, see Tier 3).
Despite these successes, the capacity to engineer transla-
tionalcontrolmechanismsisquitelimitedduetothefactthat
many initiation factors (IF) are yet to be fully characterized
and explored. Yet, initial work is beginning to unveil the
complex molecular interactions that occur at this level [99–
101]. However, studies have shown that mRNA levels do not
always correlate with protein levels [10, 102]. This disjoint
does not reconcile with the simple, reasonable hypothesis
embodied by the central dogma that increasing transcript
levelsshouldincreaseproteinlevels.However,itdoesprovide
circumstantial evidence for unknown control mechanisms
inﬂuencing translation. More studies, perhaps borrowing
from the systems biology approach to studying transcription
factors [103, 104], are required to uncover these translation-
level control mechanisms. If obtained, the full detail of
translational control systems will provide a novel means to
synthetically control the translation process unit. Therefore,
the study of translational control mechanisms should be
more fully explored by synthetic biologists.
3.3. Protein Regulation. Regulation occurs at all levels within
the cell and is not limited to simply the process units of
transcription and translation. In this regard, a great deal
of regulation takes place at the protein level, especially
upon activity and degradation rate. Also, modifying events
suchasglycosylation,phosphorylation,andacetylationallow
p r o t e i nf u n c t i o nt ob em o d u l a t e da n dl o c a l i z e dw i t h i nt h e
cell[105–107].Theseeventsregulatecellularactivitythrough
activation, inhibition, and signaling. Systems biology is delv-
ing into these complex protein-protein interaction networks
[108–115]. Supplied with this increasing amount of data,
synthetic biologists are constructing synthetic regulatory
networks [116, 117] that take advantage of these control
processes.
As stated previously, protein level within a cell is partially
regulated by degradation rates. Synthetic control of these
processes is important to (1) aid our understanding of
how to extend the half-lives of desirable proteins and (2)
further our control of regulatory and signaling systems. To
this end, a synthetic protein degradation network has been
constructed in Saccharomyces cerevisiae [118]. Eukaryotic
systems have elegant processes such as ubiquitination to
controldegradation, while prokaryotic systems werethought
not to possess such capability. However, this has been found
to not be the case. Many degradation mechanisms such
as the AAA+ protease family in E. coli [119], prokaryotic
ubiquitin-like protein (Pup) [120], and others have reversed
this thinking. As a result, understanding and engineering
protein degradation in prokaryotes can prove to be a fertile
area for synthetic biology research in the future.
Protein regulation has been studied since the very begin-
ning of the biotechnological revolution, and is presently
becoming inﬂuenced by the synthetic biology paradigm. The
work previously discussed exempliﬁes this and opens the
door to ground-up cellular optimization.
3.4. Engineering the Second Tier—Summary. The regulatory
mechanismsthatactuponthecentraldogmaprocessarevital
to optimizing cellular function, from improving product
titer to switching gene expression proﬁles. Synthetic biology
has demonstrated that these mechanisms can be eﬀectively
engineered at all levels of the central dogma process. By
altering regulatory and control systems, it will be possible
to ensure that a cell will respond in a desired manner.
This is an important trait when considering the behavior
of synthetic circuits as well as the function of metabolically
engineeredorganisms.However,moreworkneedstobedone
to establish the foundation necessary for ground-up cellular
optimization anddesignercontrolelementsthatcanleverage
these critical regulatory networks.
4. The Third Tier—EngineeringEnvironmental
Signal Reception
The central dogma and the internal control mechanisms
present in the cell have evolved to integrate and respond to
a wide array of environmental signals. A short list of stimuli
includes temperature, metabolite concentration, light, tox-
ins, ions, and molecular signals from other cells. As we begin
to probe cellular systems further, a greater appreciation is
being given to cell communication and signaling pathways.
New advances in small molecule detection are uncovering
key small molecule elicitors. Figure 2, in addition to showing
interactions at the second tier, also depicts cellular response
to a hypothetical environmental signal at the third tier. This
third tier is focused on extracellular molecules and sensing
proteins. Once an extracellular molecule interacts with a
component of either the internal control mechanisms or
of the central dogma, the information has been translated
into either the ﬁrst or second tier. Synthetic engineering
of environmental response and communication pathways
provides a unique opportunity to exert control in a cellular
system. In this section, we will review novel synthetic
approaches for signal integration and communication.Journal of Biomedicine and Biotechnology 7
Engineering at this third tier is producing some of the
newest work at the frontier of synthetic biology. This area
encompasses the work of genetic circuit construction as
well as engineering bacterial quorum sensing and microbial
consortia [121]. Advancing the toolbox for the microbial
engineer at this level is critical for external control of
microbial populations. Furthermore, this work provides a
newfound method for process control of fermentations.
Constructing synthetic sensors that can detect a particular
signaling molecule can serve as a responsive switch in a
simple genetic circuit as well as a biosensor used to detect
toxins in the environment. Furthermore, these systems can
be combined to achieve higher logic functions such as AND
gates [122]. Engineering at this ﬁnal tier is the last link in
the whole-cell chain of events: environmental signal aﬀects
control mechanism, which then elicits change in central
dogma, which aﬀects protein levels, and then produces the
desired result. As a result, synthetic control of molecular
input capability is vital for the complex functions that are
currently being designed into microbes.
4.1. Signal Receptive Genetic Circuits. Modeling biological
networks has borrowed from electrical circuits theory [123],
which has given rise to a great deal of analogies between the
two ﬁelds. The concept of the genetic circuit has become
one of the key contributions of synthetic biology [1, 124,
125]. By deﬁnition, genetic circuit design requires an input
signal, which represents engineering at the third tier. Due
t ot h em a n ye n v i r o n m e n t a lp r o p e r t i e sam i c r o b ei sa b l et o
sense, there are a plethora of inputs available to engineer.
These inputs can include metabolites [126], proteins [127],
temperature [128], and light [129]. Using these inputs,
circuits such as switches [127], oscillators [126], bandpass
ﬁlters [130], and feedback loops [131] may be constructed.
Also, it has been shown that genetic circuits can be improved
using the directed evolution algorithm typically applied to
single proteins [26].
One of the most common positive feedback loops used
in genetic circuit engineering is bacterial quorum sensing
[132–136]. This natural system of cell-cell communication
has been used to initiate cell death for population control,
cancer cell invasion [137], artiﬁcial predator-prey relation-
ships [138], and cell motility [139]. In these studies, a
synthetic quorum sensing response has been introduced into
nonnative cells to drive a desired phenotype.
Beyond feedback loops, synthetic biologists could incor-
porate environmental signals through receptor-ligand inter-
actions [140]. Not surprisingly, protein engineering tech-
niques are important to manipulate these receptor-mediated
interactions. Methods such as directed evolution [26, 87,
141]ar epr ov en,eﬀectivemethodstoaccomplishingthisend.
However, there is also an ongoing push towards rational
design of proteins [142, 143]. As this develops, synthetic
biologists will have better avenues towards ap r i o r iprotein
design. Already, there is a great deal of published work on
engineering binding pockets of proteins [140] and modeling
protein folding changes based on binding events [144].
While these studies had a direct metabolic and medical
[145] application, this approach could contribute to the
construction of artiﬁcial regulatory networks for proteins
that lack native regulation.
In addition, RNA engineering has shown that
riboswitches represent a powerful and promising way to
incorporate an environmental signal. These small fragments
of RNA are a noncoding portion of an mRNA transcript
that binds to small molecules, allosterically aﬀecting protein
activation levels in the cell [97, 146]. Moreover, the ability of
these fragments to work in an independent fashion allows
for a portable, modular assembly of responsive elements
[98]. Riboswitches present an exciting new approach to
environmental signal recognition because the sequence-
structure-function relationship is more predictable than
with that of a normal length protein [130]. Success has also
been demonstrated designing a riboswitch as a biosensor
[147], and constructing artiﬁcial switches with natural
aptamer domains [148]. There is a great deal more to
uncover about the function and applications of riboswitches,
and ongoing work in this ﬁeld will continue in that eﬀort.
4.2. Engineering the Third Tier—Summary. Environmental
signal input is essential for programming cellular function.
Using the paradigm of genetic circuits, much work has
been accomplished to this end. In this regard, the powerful
capability of bacterial quorum sensing appears to be a very
eﬀective means of synthetically controlling cells. Also, engi-
neering activation and inhibition sites into proteins would
allow greater control over biological processes, but work in
thisarealagsduetotheunsolvedproteinsequence-structure-
function problem. A third way to engineer environmental
inputs is through riboswitches, an approach that utilizes
RNA as the receptor molecule. All of these areas continue to
increase the degree to which the central dogma is rationally
controlled for speciﬁc uses. This capability, coupled with
the powerful techniques at the other two tiers, will lead to
ground-up engineering of biology.
5.IntegrativeSyntheticBiology
As the development of synthetic biology tools continues to
mature, one can envision studies moving towards ground-
up cellular optimization on a level never before seen. Armed
with powerful DNA writing technology, along with the
knowledge and ability to manipulate cellular processes, the
possibilities for the microbial engineer may become almost
limitless. This will be the stage where all of the disparate
synthetic biology tools and approaches will be able to be
fused with one another, creating the ﬁeld of integrative
synthetic biology.
To date, very few examples of this kind exist since some
of the tools and understanding of the parts are lacking.
However, recent work from the Keasling laboratory and
colleagues provides an initial picture of the type of studies
that will be done in this new ﬁeld. In order to produce
the medically valuable product artemisinin, many diﬀerent
approaches have been used, including synthetic pathway
construction [83], codon optimization [83], environmental8 Journal of Biomedicine and Biotechnology
signal detection [149], and mRNA secondary structure
engineering [95]. Each of these strategies and tools was
used in tandem to improve the biotechnological goal, and
represent the earliest examples of the power of integrative
synthetic biology.
Another example illustrating the reality of integrative
synthetic biology is work on orthogonal central dogma
machinery. It has already been discussed that the process
units of transcription and translation are under a great deal
of control, and the mechanisms concerning this control
are not yet fully understood. This may overly complicate
genetic manipulations, since heterologous gene expression
i nah o s to r g a n i s mi ss u b j e c tt ot h i sn a t i v ec e n t r a ld o g m a
machinery,andtheregulatorymechanismsmaybeunknown
or inhibitory. One approach synthetic biologists could use
to overcome this diﬃculty is by designing orthogonal,
or noninteracting, transcription and translation machinery
[150]. The concept of an orthogonal biological system is an
excellent way to avoid undesired host interference, and this
has recently been accomplished by combining the speciﬁc
T7 bacterial promoter system with a previously developed
orthogonalribosome-rRNApair[151].This,ineﬀect,creates
two AND gates that must be satisﬁed for heterologous gene
expression. Using these types of constructs for engineering
control systems and integration of environmental signals
may provide the fundamental knowledge needed to under-
stand the more complex and interrelated systems of natural
organisms, leading us one step closer to ground-up cellular
optimization.
The integrative synthetic biology approach should bring
the ability to perform wholesale cellular remodeling into
the scope of a single research project. However, as has been
iterated at many points in this review, much more basic
knowledge and foundational research must be made in order
to realize this scenario. In particular, our ability to predict
and design components lags behind our ability to engineer
them. However, the transformative work that is continually
beingdoneinsyntheticbiologyinspiresconﬁdencethatthese
techniques may soon be at the ﬁngertips of the microbial
engineer.
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